Condition

Treatment

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 22 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials22

Recruiting3

Common interventions25

Lead sponsors shown15

Clinical trials

22 shown

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical TrialNCT06176534 · 2024-01-01

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%NCT03351842 · 2017-09-01

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani PopulationNCT06830590 · 2016-02-01

Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual TreatmentNCT06828640 · 2024-10-16

Influence of Type 1 Diabetes (T1DM) Treatment Type on Mental WorkloadNCT06165159 · 2024-01-01

First in Human Study of TLC-ART 101 (ACTU 2001)NCT05850728 · 2023-04-01

Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone AdministrationNCT06223074 · 2023-01-09

ENROLLING_BY_INVITATION

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate CancerNCT04599686 · 2022-09-11

Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant TherapyNCT05285332 · 2022-08-01

NOT_YET_RECRUITING

Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's DiseaseNCT05430867 · 2022-07-01

Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate CancerNCT04278261 · 2022-07-01

Integrated Boost to the Dominant Intraprostatic Nodule Based on Ga-68 PSMA PET/MR Study of SBRT With Prostate CancerNCT04599699 · 2020-11-01

Brief Acceptance and Commitment Therapy for HIV-infected At-risk DrinkersNCT03974061 · 2019-11-01

Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque ImagingNCT02931136 · 2019-11-01

Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFRNCT05767866 · 2018-03-30

Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)NCT02782442 · 2016-09-01

Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung AdenocarcinomaNCT02951897 · 2016-04-01

Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese WomenNCT01756105 · 2012-06-01

Aerobic Training, Aerobic-resistance Training and Glucose Profile (CGMS) in Type 2 DiabetesNCT00887094 · 2009-06-01

fMRI Study of Treatment Changes in Major DepressionNCT01027559 · 2009-02-01

The Medication Adherence ProgramNCT00838344 · 2008-04-01

Korea National Diabetes ProgramNCT01212198 · 2005-05-01

Common interventions

Active Comparator: endocrine therapyDRUG1 Acute aerobic exerciseBEHAVIORAL1 Acute aerobic-resistance exerciseBEHAVIORAL1 ADTDRUG1 Brief Acceptance and Commitment TherapyBEHAVIORAL1 Brief Alcohol InterventionBEHAVIORAL1 CanPatrolTM to detect CTCsOTHER1 chemotherapy（pemetrexed+CISPLATIN）DRUG1 children and adolescents with type 1 diabetes and their parentsOTHER1 cis Platinum/Carboplatin, Pemetrexed DisodiumDRUG1 Cognitive Behavioral TherapyBEHAVIORAL1 Computer Games Control & PRIMEBEHAVIORAL1 Experimental: chemotheyapyDRUG1 Focal therapy(high-frequency irreversible electroporation)PROCEDURE1 GV-971 capsuleDRUG1 Huperzine ADRUG1 IV Methylprednisolone administrationOTHER1 laparoscopic radical prostatectomyPROCEDURE1 lobectomyPROCEDURE1 LymphadenectomyPROCEDURE1 Medication Adherence Program (MAP)OTHER1 Memantine Oral TabletDRUG1 MetforminDRUG1 Molecular characterisationPROCEDURE1 Nasal Methylprednisolone (MT)DRUG1

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

huperzine A1 memantine Oral Tablet1 metformin1 placebo1 sertraline1

Leading sponsors

Changhai Hospital 3 University of Washington 2 Centre Hospitalier Universitaire Saint Pierre 1 First Affiliated Hospital Xi'an Jiaotong University 1 Henan Cancer Hospital 1 Hospital de Clinicas de Porto Alegre 1 Kyunghee University Medical Center 1 Liaquat University of Medical & Health Sciences 1 Shanghai East Hospital 1 Shanghai Mental Health Center 1 Shanghai Pulmonary Hospital, Shanghai, China 1 Suzhou Puhe Pharmaceutical Technology Co., LTD 1 Syracuse University 1 Third Military Medical University 1 Universidad Nacional Autonoma de Mexico 1

Trial status mix

UNKNOWN11

COMPLETED5

RECRUITING3

ENROLLING_BY_INVITATION1

NOT_YET_RECRUITING1

TERMINATED1

Phase mix

NA11

PHASE25

PHASE12

PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.